Soleus PE GP I, LLC's Net Worth
-$1.72 Million
Who is Soleus PE GP I, LLC?
Soleus PE GP I, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lyra Therapeutics, Inc., and BioAtla, Inc..
SEC CIK
Soleus PE GP I, LLC's CIK is 0001812274
Past Insider Trading and Trends
2020 was Soleus PE GP I, LLC's most active year for acquiring shares with 4 total transactions. Soleus PE GP I, LLC's most active month to acquire stocks was the month of April. 2020 was Soleus PE GP I, LLC's most active year for disposing of shares, totalling 4 transactions. Soleus PE GP I, LLC's most active month to dispose stocks was the month of April. 2020 saw Soleus PE GP I, LLC paying a total of $2,750,826.66 for 629,320 shares, this is the most they've acquired in one year. In 2020 Soleus PE GP I, LLC cashed out on 15,322,181 shares for a total of $270,544.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +181.00% | 612.41K |
$14.16 | $2,480,282.66 | 950.75K |
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioAtla, Inc. (BCAB) Snapshot price: $2.795
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||